The Port Delivery System With Ranibizumab: A New Paradigm for Long-Acting Retinal Drug Delivery

26 September 2022 13:50 - 14:25

Session Abstract (TBC)

Shrirang Ranade, Sr. Technical Development (CMC) Team Leader, Genentech

Back to programme